ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Enuresis Treatment Drugs Market Outlook, In‑Depth Analysis & Forecast to 2031
Published Date: November 2025
|
Report Code: QYRE-Auto-17F17049
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Enuresis Treatment Drugs Market Research Report 2024
BUY CHAPTERS

Global Enuresis Treatment Drugs Market Outlook, In‑Depth Analysis & Forecast to 2031

Code: QYRE-Auto-17F17049
Report
November 2025
Pages:140
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Allergan plc
Ferring Pharmaceuticals, Inc.
Pfizer Inc
Bayer Corp
Mallinckrodt plc
Shanghai Xudong Haipu Pharmaceutical Co., Ltd
Guangdong Xianqiang Pharmaceutical Co., Ltd
Beijing Zizhu Pharmaceutical Co., Ltd
Shanghai Pharmaceutical Group

Enuresis Treatment Drugs Market

The global Enuresis Treatment Drugs market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications.
From a downstream perspective, Hospital accounted for % of 2024 revenue, surging to US$ million by 2031 (CAGR: % from 2025–2031).
Enuresis Treatment Drugs leading manufacturers including Allergan, Ferring Pharmaceuticals, Inc., Pfizer Inc., Janssen Pharmaceuticals, Inc., Urovant Sciences, Inc., Astellas Pharma US, Inc., Bayer Corp, Mallinckrodt, Inc., Shanghai Xudong Haipu Pharmaceutical Co., Ltd, Guangdong Xianqiang Pharmaceutical Co., Ltd, etc., dominate supply; the top five capture approximately % of global revenue, with Allergan leading 2024 sales at US$ million.
Regional Outlook:
North America rose from US$ million in 2024 to a forecast US$ million by 2031 (CAGR %).
Asia‑Pacific will expand from US$ million to US$ million (CAGR  %), led by China (US$ million in 2024, % share rising to % by 2031), Japan (CAGR %), South Korea (CAGR %), and Southeast Asia (CAGR %).
Europe is set to grow from US$ million to US$ million (CAGR %), with Germany projected to hit US$ million by 2031 (CAGR %).

Report Includes:

This definitive report equips CEOs, marketing directors, and investors with a 360° view of the global Enuresis Treatment Drugs market across value chain. It analyzes historical revenue data (2020–2024) and delivers forecasts through 2031, illuminating demand trends and growth drivers.
By segmenting the market by Type and by Application, the study quantifies market size, growth rates, niche opportunities, and substitution risks, and analyzes downstream customers distribution pattern.
Granular regional insights cover five major markets—North America, Europe, APAC, South America, and MEA—with in‑depth analysis of 20+ countries, detailing dominant products, competitive landscape, and downstream demand trends.
Critical competitive intelligence profiles players—revenue, margins, pricing strategies, and major customers—and dissects the top-player positioning across product lines, applications, and regions to reveal strategic strengths.
A concise Industry‑chain overview maps upstream, middlestream, and downstream distribution dynamics to identify strategic gaps and unmet demand.
Market Segmentation

Scope of Enuresis Treatment Drugs Market Report

Report Metric Details
Report Name Enuresis Treatment Drugs Market
Segment by Type
  • Desmopressin(DDAVP)
  • Tofranil
  • Others
Segment by Application
  • Hospital
  • Specialist Clinic
  • Others
Sales by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Allergan, Ferring Pharmaceuticals, Inc., Pfizer Inc., Janssen Pharmaceuticals, Inc., Urovant Sciences, Inc., Astellas Pharma US, Inc., Bayer Corp, Mallinckrodt, Inc., Shanghai Xudong Haipu Pharmaceutical Co., Ltd, Guangdong Xianqiang Pharmaceutical Co., Ltd, Beijing Zizhu Pharmaceutical Co., Ltd, Shanghai Pharmaceutical Group
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Defines the Enuresis Treatment Drugs study scope, segments the market by Type and by Application, etc, highlights segment size and growth potential.
  • Chapter 2: Offers current market state, projects global revenue and sales to 2031, pinpointing high consumption regions and emerging market catalysts
  • Chapter 3: Dissects the player landscape—ranks by revenue and profitability, details Player performance by product type and evaluates concentration alongside M&A moves.
  • Chapter 4: Unlocks high margin product segments—compares revenue, ASP, and technology differentiators, highlighting growth niches and substitution risks
  • Chapter 5: Targets downstream market opportunities—evaluates market size by Application, identifies emerging use cases, and profiles leading customers by region and by Application.
  • Chapter 6: North America—breaks down market size by Type, by Application and country, profiles key players and assesses growth drivers and barriers.
  • Chapter 7: Europe—analyses regional market by Type, by Application and players, flagging drivers and barriers.
  • Chapter 8: Asia Pacific—quantifies market size by Type, by Application, and region/country, profiles top players, and uncovers high potential expansion areas.
  • Chapter 9: Central & South America—measures market size by Type, by Application, and country, profiles top players, and identifies investment opportunities and challenges.
  • Chapter 10: Middle East and Africa—evaluates market size by Type, by Application, and country, profiles key players, and outlines investment prospects and market hurdles
  • Chapter 11: Profiles players in depth—details product specs, revenue, margins; Top-tier players 2024 sales breakdowns by Product type, by Application, by region SWOT analysis, and recent strategic developments.
  • Chapter 12: Industry chain—analyses upstream, cost drivers, plus downstream channels.
  • Chapter 13: Market dynamics—explores drivers, restraints, regulatory impacts, and risk mitigation strategies.
  • Chapter 14: Actionable conclusions and strategic recommendations.
  • Why This Report:
  • Beyond standard market data, this analysis provides a clear profitability roadmap—empowering you to:
  • Allocate capital strategically to high growth regions (Chapters 6–10) and margin rich segments (Chapter 5).
  • Negotiate from strength with suppliers (Chapter 12) and customers (Chapter 5) using cost and demand intelligence.
  • Outmaneuver competitors with granular insights into their operations, margins, and strategies (Chapters 3 and 11).
  • Capitalize on the projected billion‑dollar opportunity with data‑driven regional and segment tactics (Chapter 12-14).
  • Leverage this 360° intelligence to turn market complexity into actionable competitive advantage.

FAQ for this report

Who are the main players in the Enuresis Treatment Drugs Market report?

Ans: The main players in the Enuresis Treatment Drugs Market are Allergan, Ferring Pharmaceuticals, Inc., Pfizer Inc., Janssen Pharmaceuticals, Inc., Urovant Sciences, Inc., Astellas Pharma US, Inc., Bayer Corp, Mallinckrodt, Inc., Shanghai Xudong Haipu Pharmaceutical Co., Ltd, Guangdong Xianqiang Pharmaceutical Co., Ltd, Beijing Zizhu Pharmaceutical Co., Ltd, Shanghai Pharmaceutical Group

What are the Application segmentation covered in the Enuresis Treatment Drugs Market report?

Ans: The Applications covered in the Enuresis Treatment Drugs Market report are Hospital, Specialist Clinic, Others

What are the Type segmentation covered in the Enuresis Treatment Drugs Market report?

Ans: The Types covered in the Enuresis Treatment Drugs Market report are Desmopressin(DDAVP), Tofranil, Others

1 Study Coverage
1.1 Introduction to Enuresis Treatment Drugs: Definition, Properties, and Key Attributes
1.2 Market Segmentation by Type
1.2.1 Global Enuresis Treatment Drugs Market Size by Type, 2020 VS 2024 VS 2031
1.2.2 Desmopressin(DDAVP)
1.2.3 Tofranil
1.2.4 Others
1.3 Market Segmentation by Application
1.3.1 Global Enuresis Treatment Drugs Market Size by Application, 2020 VS 2024 VS 2031
1.3.2 Hospital
1.3.3 Specialist Clinic
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Enuresis Treatment Drugs Revenue Estimates and Forecasts 2020-2031
2.2 Global Enuresis Treatment Drugs Revenue by Region
2.2.1 Revenue Comparison: 2020 VS 2024 VS 2031
2.2.2 Historical and Forecasted Revenue by Region (2020-2031)
2.2.3 Global Revenue Market Share by Region (2020-2031)
2.2.4 Emerging Market Focus: Growth Drivers & Investment Trends
3 Competition by Players
3.1 Global Enuresis Treatment Drugs Player Revenue Rankings and Profitability
3.1.1 Global Revenue (Value) by Players (2020-2025)
3.1.2 Global Key Player Revenue Ranking (2023 vs. 2024)
3.1.3 Revenue-Based Tier Segmentation (Tier 1, Tier 2, and Tier 3)
3.1.4 Gross Margin by Top Player (2020 VS 2024)
3.2 Global Enuresis Treatment Drugs Companies Headquarters and Service Footprint
3.3 Main Product Type Market Size by Players
3.3.1 Desmopressin(DDAVP) Market Size by Players
3.3.2 Tofranil Market Size by Players
3.3.3 Others Market Size by Players
3.4 Global Enuresis Treatment Drugs Market Concentration and Dynamics
3.4.1 Global Market Concentration (CR5 and HHI)
3.4.2 Entrant/Exit Impact Analysis
3.4.3 Strategic Moves: M&A, Expansion, R&D Investment
4 Global Product Segmentation Analysis
4.1 Global Enuresis Treatment Drugs Revenue Trends by Type
4.1.1 Global Historical and Forecasted Revenue by Type (2020-2031)
4.1.2 Global Revenue Market Share by Type (2020-2031)
4.2 Key Product Attributes and Differentiation
4.3 Subtype Dynamics: Growth Leaders, Profitability and Risk
4.3.1 High-Growth Niches and Adoption Drivers
4.3.2 Profitability Hotspots and Cost Drivers
4.3.3 Substitution Threats
5 Global Downstream Application Analysis
5.1 Global Enuresis Treatment Drugs Revenue by Application
5.1.1 Global Historical and Forecasted Revenue by Application (2020-2031)
5.1.2 Revenue Market Share by Application (2020-2031)
5.1.3 High-Growth Application Identification
5.1.4 Emerging Application Case Studies
5.2 Downstream Customer Analysis
5.2.1 Top Customers by Region
5.2.2 Top Customers by Application
6 North America
6.1 North America Market Size (2020-2031)
6.2 North America Key Players Revenue in 2024
6.3 North America Enuresis Treatment Drugs Market Size by Type (2020-2031)
6.4 North America Enuresis Treatment Drugs Market Size by Application (2020-2031)
6.5 North America Growth Accelerators and Market Barriers
6.6 North America Enuresis Treatment Drugs Market Size by Country
6.6.1 North America Revenue Trends by Country
6.6.2 US
6.6.3 Canada
6.6.4 Mexico
7 Europe
7.1 Europe Market Size (2020-2031)
7.2 Europe Key Players Revenue in 2024
7.3 Europe Enuresis Treatment Drugs Market Size by Type (2020-2031)
7.4 Europe Enuresis Treatment Drugs Market Size by Application (2020-2031)
7.5 Europe Growth Accelerators and Market Barriers
7.6 Europe Enuresis Treatment Drugs Market Size by Country
7.6.1 Europe Revenue Trends by Country
7.6.2 Germany
7.6.3 France
7.6.4 U.K.
7.6.5 Italy
7.6.6 Russia
8 Asia-Pacific
8.1 Asia-Pacific Market Size (2020-2031)
8.2 Asia-Pacific Key Players Revenue in 2024
8.3 Asia-Pacific Enuresis Treatment Drugs Market Size by Type (2020-2031)
8.4 Asia-Pacific Enuresis Treatment Drugs Market Size by Application (2020-2031)
8.5 Asia-Pacific Growth Accelerators and Market Barriers
8.6 Asia-Pacific Enuresis Treatment Drugs Market Size by Region
8.6.1 Asia-Pacific Revenue Trends by Region
8.7 China
8.8 Japan
8.9 South Korea
8.10 Australia
8.11 India
8.12 Southeast Asia
8.12.1 Indonesia
8.12.2 Vietnam
8.12.3 Malaysia
8.12.4 Philippines
8.12.5 Singapore
9 Central and South America
9.1 Central and South America Market Size (2020-2031)
9.2 Central and South America Key Players Revenue in 2024
9.3 Central and South America Enuresis Treatment Drugs Market Size by Type (2020-2031)
9.4 Central and South America Enuresis Treatment Drugs Market Size by Application (2020-2031)
9.5 Central and South America Investment Opportunities and Key Challenges
9.6 Central and South America Enuresis Treatment Drugs Market Size by Country
9.6.1 Central and South America Revenue Trends by Country (2020 VS 2024 VS 2031)
9.6.2 Brazil
9.6.3 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Market Size (2020-2031)
10.2 Middle East and Africa Key Players Revenue in 2024
10.3 Middle East and Africa Enuresis Treatment Drugs Market Size by Type (2020-2031)
10.4 Middle East and Africa Enuresis Treatment Drugs Market Size by Application (2020-2031)
10.5 Middle East and Africa Investment Opportunities and Key Challenges
10.6 Middle East and Africa Enuresis Treatment Drugs Market Size by Country
10.6.1 Middle East and Africa Revenue Trends by Country (2020 VS 2024 VS 2031)
10.6.2 GCC Countries
10.6.3 Israel
10.6.4 Egypt
10.6.5 South Africa
11 Corporate Profile
11.1 Allergan
11.1.1 Allergan Corporation Information
11.1.2 Allergan Business Overview
11.1.3 Allergan Enuresis Treatment Drugs Product Features and Attributes
11.1.4 Allergan Enuresis Treatment Drugs Revenue and Gross Margin (2020-2025)
11.1.5 Allergan Enuresis Treatment Drugs Revenue by Product in 2024
11.1.6 Allergan Enuresis Treatment Drugs Revenue by Application in 2024
11.1.7 Allergan Enuresis Treatment Drugs Revenue by Geographic Area in 2024
11.1.8 Allergan Enuresis Treatment Drugs SWOT Analysis
11.1.9 Allergan Recent Developments
11.2 Ferring Pharmaceuticals, Inc.
11.2.1 Ferring Pharmaceuticals, Inc. Corporation Information
11.2.2 Ferring Pharmaceuticals, Inc. Business Overview
11.2.3 Ferring Pharmaceuticals, Inc. Enuresis Treatment Drugs Product Features and Attributes
11.2.4 Ferring Pharmaceuticals, Inc. Enuresis Treatment Drugs Revenue and Gross Margin (2020-2025)
11.2.5 Ferring Pharmaceuticals, Inc. Enuresis Treatment Drugs Revenue by Product in 2024
11.2.6 Ferring Pharmaceuticals, Inc. Enuresis Treatment Drugs Revenue by Application in 2024
11.2.7 Ferring Pharmaceuticals, Inc. Enuresis Treatment Drugs Revenue by Geographic Area in 2024
11.2.8 Ferring Pharmaceuticals, Inc. Enuresis Treatment Drugs SWOT Analysis
11.2.9 Ferring Pharmaceuticals, Inc. Recent Developments
11.3 Pfizer Inc.
11.3.1 Pfizer Inc. Corporation Information
11.3.2 Pfizer Inc. Business Overview
11.3.3 Pfizer Inc. Enuresis Treatment Drugs Product Features and Attributes
11.3.4 Pfizer Inc. Enuresis Treatment Drugs Revenue and Gross Margin (2020-2025)
11.3.5 Pfizer Inc. Enuresis Treatment Drugs Revenue by Product in 2024
11.3.6 Pfizer Inc. Enuresis Treatment Drugs Revenue by Application in 2024
11.3.7 Pfizer Inc. Enuresis Treatment Drugs Revenue by Geographic Area in 2024
11.3.8 Pfizer Inc. Enuresis Treatment Drugs SWOT Analysis
11.3.9 Pfizer Inc. Recent Developments
11.4 Janssen Pharmaceuticals, Inc.
11.4.1 Janssen Pharmaceuticals, Inc. Corporation Information
11.4.2 Janssen Pharmaceuticals, Inc. Business Overview
11.4.3 Janssen Pharmaceuticals, Inc. Enuresis Treatment Drugs Product Features and Attributes
11.4.4 Janssen Pharmaceuticals, Inc. Enuresis Treatment Drugs Revenue and Gross Margin (2020-2025)
11.4.5 Janssen Pharmaceuticals, Inc. Enuresis Treatment Drugs Revenue by Product in 2024
11.4.6 Janssen Pharmaceuticals, Inc. Enuresis Treatment Drugs Revenue by Application in 2024
11.4.7 Janssen Pharmaceuticals, Inc. Enuresis Treatment Drugs Revenue by Geographic Area in 2024
11.4.8 Janssen Pharmaceuticals, Inc. Enuresis Treatment Drugs SWOT Analysis
11.4.9 Janssen Pharmaceuticals, Inc. Recent Developments
11.5 Urovant Sciences, Inc.
11.5.1 Urovant Sciences, Inc. Corporation Information
11.5.2 Urovant Sciences, Inc. Business Overview
11.5.3 Urovant Sciences, Inc. Enuresis Treatment Drugs Product Features and Attributes
11.5.4 Urovant Sciences, Inc. Enuresis Treatment Drugs Revenue and Gross Margin (2020-2025)
11.5.5 Urovant Sciences, Inc. Enuresis Treatment Drugs Revenue by Product in 2024
11.5.6 Urovant Sciences, Inc. Enuresis Treatment Drugs Revenue by Application in 2024
11.5.7 Urovant Sciences, Inc. Enuresis Treatment Drugs Revenue by Geographic Area in 2024
11.5.8 Urovant Sciences, Inc. Enuresis Treatment Drugs SWOT Analysis
11.5.9 Urovant Sciences, Inc. Recent Developments
11.6 Astellas Pharma US, Inc.
11.6.1 Astellas Pharma US, Inc. Corporation Information
11.6.2 Astellas Pharma US, Inc. Business Overview
11.6.3 Astellas Pharma US, Inc. Enuresis Treatment Drugs Product Features and Attributes
11.6.4 Astellas Pharma US, Inc. Enuresis Treatment Drugs Revenue and Gross Margin (2020-2025)
11.6.5 Astellas Pharma US, Inc. Recent Developments
11.7 Bayer Corp
11.7.1 Bayer Corp Corporation Information
11.7.2 Bayer Corp Business Overview
11.7.3 Bayer Corp Enuresis Treatment Drugs Product Features and Attributes
11.7.4 Bayer Corp Enuresis Treatment Drugs Revenue and Gross Margin (2020-2025)
11.7.5 Bayer Corp Recent Developments
11.8 Mallinckrodt, Inc.
11.8.1 Mallinckrodt, Inc. Corporation Information
11.8.2 Mallinckrodt, Inc. Business Overview
11.8.3 Mallinckrodt, Inc. Enuresis Treatment Drugs Product Features and Attributes
11.8.4 Mallinckrodt, Inc. Enuresis Treatment Drugs Revenue and Gross Margin (2020-2025)
11.8.5 Mallinckrodt, Inc. Recent Developments
11.9 Shanghai Xudong Haipu Pharmaceutical Co., Ltd
11.9.1 Shanghai Xudong Haipu Pharmaceutical Co., Ltd Corporation Information
11.9.2 Shanghai Xudong Haipu Pharmaceutical Co., Ltd Business Overview
11.9.3 Shanghai Xudong Haipu Pharmaceutical Co., Ltd Enuresis Treatment Drugs Product Features and Attributes
11.9.4 Shanghai Xudong Haipu Pharmaceutical Co., Ltd Enuresis Treatment Drugs Revenue and Gross Margin (2020-2025)
11.9.5 Shanghai Xudong Haipu Pharmaceutical Co., Ltd Recent Developments
11.10 Guangdong Xianqiang Pharmaceutical Co., Ltd
11.10.1 Guangdong Xianqiang Pharmaceutical Co., Ltd Corporation Information
11.10.2 Guangdong Xianqiang Pharmaceutical Co., Ltd Business Overview
11.10.3 Guangdong Xianqiang Pharmaceutical Co., Ltd Enuresis Treatment Drugs Product Features and Attributes
11.10.4 Guangdong Xianqiang Pharmaceutical Co., Ltd Enuresis Treatment Drugs Revenue and Gross Margin (2020-2025)
11.10.5 Company Ten Recent Developments
11.11 Beijing Zizhu Pharmaceutical Co., Ltd
11.11.1 Beijing Zizhu Pharmaceutical Co., Ltd Corporation Information
11.11.2 Beijing Zizhu Pharmaceutical Co., Ltd Business Overview
11.11.3 Beijing Zizhu Pharmaceutical Co., Ltd Enuresis Treatment Drugs Product Features and Attributes
11.11.4 Beijing Zizhu Pharmaceutical Co., Ltd Enuresis Treatment Drugs Revenue and Gross Margin (2020-2025)
11.11.5 Beijing Zizhu Pharmaceutical Co., Ltd Recent Developments
11.12 Shanghai Pharmaceutical Group
11.12.1 Shanghai Pharmaceutical Group Corporation Information
11.12.2 Shanghai Pharmaceutical Group Business Overview
11.12.3 Shanghai Pharmaceutical Group Enuresis Treatment Drugs Product Features and Attributes
11.12.4 Shanghai Pharmaceutical Group Enuresis Treatment Drugs Revenue and Gross Margin (2020-2025)
11.12.5 Shanghai Pharmaceutical Group Recent Developments
12 Enuresis Treatment DrugsIndustry Chain Analysis
12.1 Enuresis Treatment Drugs Industry Chain
12.2 Upstream Analysis
12.2.1 Upstream Key Suppliers
12.3 Middlestream Analysis
12.4 Downstream Sales Model and Distribution Networks
12.4.1 Sales Channels
12.4.2 Distributors
13 Enuresis Treatment Drugs Market Dynamics
13.1 Industry Trends and Evolution
13.2 Market Growth Drivers and Emerging Opportunities
13.3 Market Challenges, Risks, and Restraints
14 Key Findings in the Global Enuresis Treatment Drugs Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Author Details
FEATURED COMPANIES
Allergan plc
Ferring Pharmaceuticals, Inc.
Pfizer Inc
Bayer Corp
Mallinckrodt plc
Shanghai Xudong Haipu Pharmaceutical Co., Ltd
Guangdong Xianqiang Pharmaceutical Co., Ltd
Beijing Zizhu Pharmaceutical Co., Ltd
Shanghai Pharmaceutical Group
List of Tables
 Table 1. Global Enuresis Treatment Drugs Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
 Table 2. Global Enuresis Treatment Drugs Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
 Table 3. Global Enuresis Treatment Drugs Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 4. Global Enuresis Treatment Drugs Revenue by Region (2020-2025) & (US$ Million)
 Table 5. Global Enuresis Treatment Drugs Revenue by Region (2026-2031) & (US$ Million)
 Table 6. Emerging Market Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 7. Global Enuresis Treatment Drugs Revenue by Players (2020-2025) & (US$ Million)
 Table 8. Global Enuresis Treatment Drugs Revenue Market Share by Players (2020-2025)
 Table 9. Global Key Players’Ranking Shift (2023 vs. 2024) (Based on Revenue)
 Table 10. Global Enuresis Treatment Drugs by Player Tier (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Enuresis Treatment Drugs as of 2024)
 Table 11. Global Enuresis Treatment Drugs Average Gross Margin (%) by Player (2020 VS 2024)
 Table 12. Global Enuresis Treatment Drugs Companies Headquarters
 Table 13. Global Enuresis Treatment Drugs Market Concentration Ratio (CR5 and HHI)
 Table 14. Key Market Entrant/Exit (2020-2024) – Drivers & Impact Analysis
 Table 15. Key Mergers & Acquisitions, Expansion Plans, R&D Investment
 Table 16. Global Enuresis Treatment Drugs Revenue by Type (2020-2025) & (US$ Million)
 Table 17. Global Enuresis Treatment Drugs Revenue by Type (2026-2031) & (US$ Million)
 Table 18. Key Product Attributes and Differentiation
 Table 19. Global Enuresis Treatment Drugs Revenue by Application (2020-2025) & (US$ Million)
 Table 20. Global Enuresis Treatment Drugs Revenue by Application (2026-2031) & (US$ Million)
 Table 21. Enuresis Treatment Drugs High-Growth Sectors Demand CAGR (2024-2031)
 Table 22. Top Customers by Region
 Table 23. Top Customers by Application
 Table 24. North America Enuresis Treatment Drugs Growth Accelerators and Market Barriers
 Table 25. North America Enuresis Treatment Drugs Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 26. Europe Enuresis Treatment Drugs Growth Accelerators and Market Barriers
 Table 27. Europe Enuresis Treatment Drugs Revenue Grow Rate (CAGR) by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 28. Asia-Pacific Enuresis Treatment Drugs Growth Accelerators and Market Barriers
 Table 29. Asia-Pacific Enuresis Treatment Drugs Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 30. Central and South America Enuresis Treatment Drugs Investment Opportunities and Key Challenges
 Table 31. Central and South America Enuresis Treatment Drugs Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 32. Middle East and Africa Enuresis Treatment Drugs Investment Opportunities and Key Challenges
 Table 33. Middle East and Africa Enuresis Treatment Drugs Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 34. Allergan Corporation Information
 Table 35. Allergan Description and Major Businesses
 Table 36. Allergan Product Features and Attributes
 Table 37. Allergan Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 38. Allergan Revenue Proportion by Product in 2024
 Table 39. Allergan Revenue Proportion by Application in 2024
 Table 40. Allergan Revenue Proportion by Geographic Area in 2024
 Table 41. Allergan Enuresis Treatment Drugs SWOT Analysis
 Table 42. Allergan Recent Developments
 Table 43. Ferring Pharmaceuticals, Inc. Corporation Information
 Table 44. Ferring Pharmaceuticals, Inc. Description and Major Businesses
 Table 45. Ferring Pharmaceuticals, Inc. Product Features and Attributes
 Table 46. Ferring Pharmaceuticals, Inc. Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 47. Ferring Pharmaceuticals, Inc. Revenue Proportion by Product in 2024
 Table 48. Ferring Pharmaceuticals, Inc. Revenue Proportion by Application in 2024
 Table 49. Ferring Pharmaceuticals, Inc. Revenue Proportion by Geographic Area in 2024
 Table 50. Ferring Pharmaceuticals, Inc. Enuresis Treatment Drugs SWOT Analysis
 Table 51. Ferring Pharmaceuticals, Inc. Recent Developments
 Table 52. Pfizer Inc. Corporation Information
 Table 53. Pfizer Inc. Description and Major Businesses
 Table 54. Pfizer Inc. Product Features and Attributes
 Table 55. Pfizer Inc. Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 56. Pfizer Inc. Revenue Proportion by Product in 2024
 Table 57. Pfizer Inc. Revenue Proportion by Application in 2024
 Table 58. Pfizer Inc. Revenue Proportion by Geographic Area in 2024
 Table 59. Pfizer Inc. Enuresis Treatment Drugs SWOT Analysis
 Table 60. Pfizer Inc. Recent Developments
 Table 61. Janssen Pharmaceuticals, Inc. Corporation Information
 Table 62. Janssen Pharmaceuticals, Inc. Description and Major Businesses
 Table 63. Janssen Pharmaceuticals, Inc. Product Features and Attributes
 Table 64. Janssen Pharmaceuticals, Inc. Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 65. Janssen Pharmaceuticals, Inc. Revenue Proportion by Product in 2024
 Table 66. Janssen Pharmaceuticals, Inc. Revenue Proportion by Application in 2024
 Table 67. Janssen Pharmaceuticals, Inc. Revenue Proportion by Geographic Area in 2024
 Table 68. Janssen Pharmaceuticals, Inc. Enuresis Treatment Drugs SWOT Analysis
 Table 69. Janssen Pharmaceuticals, Inc. Recent Developments
 Table 70. Urovant Sciences, Inc. Corporation Information
 Table 71. Urovant Sciences, Inc. Description and Major Businesses
 Table 72. Urovant Sciences, Inc. Product Features and Attributes
 Table 73. Urovant Sciences, Inc. Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 74. Urovant Sciences, Inc. Revenue Proportion by Product in 2024
 Table 75. Urovant Sciences, Inc. Revenue Proportion by Application in 2024
 Table 76. Urovant Sciences, Inc. Revenue Proportion by Geographic Area in 2024
 Table 77. Urovant Sciences, Inc. Enuresis Treatment Drugs SWOT Analysis
 Table 78. Urovant Sciences, Inc. Recent Developments
 Table 79. Astellas Pharma US, Inc. Corporation Information
 Table 80. Astellas Pharma US, Inc. Description and Major Businesses
 Table 81. Astellas Pharma US, Inc. Product Features and Attributes
 Table 82. Astellas Pharma US, Inc. Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 83. Astellas Pharma US, Inc. Recent Developments
 Table 84. Bayer Corp Corporation Information
 Table 85. Bayer Corp Description and Major Businesses
 Table 86. Bayer Corp Product Features and Attributes
 Table 87. Bayer Corp Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 88. Bayer Corp Recent Developments
 Table 89. Mallinckrodt, Inc. Corporation Information
 Table 90. Mallinckrodt, Inc. Description and Major Businesses
 Table 91. Mallinckrodt, Inc. Product Features and Attributes
 Table 92. Mallinckrodt, Inc. Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 93. Mallinckrodt, Inc. Recent Developments
 Table 94. Shanghai Xudong Haipu Pharmaceutical Co., Ltd Corporation Information
 Table 95. Shanghai Xudong Haipu Pharmaceutical Co., Ltd Description and Major Businesses
 Table 96. Shanghai Xudong Haipu Pharmaceutical Co., Ltd Product Features and Attributes
 Table 97. Shanghai Xudong Haipu Pharmaceutical Co., Ltd Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 98. Shanghai Xudong Haipu Pharmaceutical Co., Ltd Recent Developments
 Table 99. Guangdong Xianqiang Pharmaceutical Co., Ltd Corporation Information
 Table 100. Guangdong Xianqiang Pharmaceutical Co., Ltd Description and Major Businesses
 Table 101. Guangdong Xianqiang Pharmaceutical Co., Ltd Product Features and Attributes
 Table 102. Guangdong Xianqiang Pharmaceutical Co., Ltd Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 103. Guangdong Xianqiang Pharmaceutical Co., Ltd Recent Developments
 Table 104. Beijing Zizhu Pharmaceutical Co., Ltd Corporation Information
 Table 105. Beijing Zizhu Pharmaceutical Co., Ltd Description and Major Businesses
 Table 106. Beijing Zizhu Pharmaceutical Co., Ltd Product Features and Attributes
 Table 107. Beijing Zizhu Pharmaceutical Co., Ltd Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 108. Beijing Zizhu Pharmaceutical Co., Ltd Recent Developments
 Table 109. Shanghai Pharmaceutical Group Corporation Information
 Table 110. Shanghai Pharmaceutical Group Description and Major Businesses
 Table 111. Shanghai Pharmaceutical Group Product Features and Attributes
 Table 112. Shanghai Pharmaceutical Group Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 113. Shanghai Pharmaceutical Group Recent Developments
 Table 114. Raw Materials Key Suppliers
 Table 115. Distributors List
 Table 116. Market Trends and Market Evolution
 Table 117. Market Drivers and Opportunities
 Table 118. Market Challenges, Risks, and Restraints
 Table 119. Research Programs/Design for This Report
 Table 120. Key Data Information from Secondary Sources
 Table 121. Key Data Information from Primary Sources


List of Figures
 Figure 1. Enuresis Treatment Drugs Product Picture
 Figure 2. Global Enuresis Treatment Drugs Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
 Figure 3. Desmopressin(DDAVP) Product Picture
 Figure 4. Tofranil Product Picture
 Figure 5. Others Product Picture
 Figure 6. Global Enuresis Treatment Drugs Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
 Figure 7. Hospital
 Figure 8. Specialist Clinic
 Figure 9. Others
 Figure 10. Enuresis Treatment Drugs Report Years Considered
 Figure 11. Global Enuresis Treatment Drugs Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 12. Global Enuresis Treatment Drugs Revenue (2020-2031) & (US$ Million)
 Figure 13. Global Enuresis Treatment Drugs Revenue (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Figure 14. Global Enuresis Treatment Drugs Revenue Market Share by Region (2020-2031)
 Figure 15. Global Enuresis Treatment Drugs Revenue Market Share Ranking (2024)
 Figure 16. Tier Distribution by Revenue Contribution (2020 VS 2024)
 Figure 17. Desmopressin(DDAVP) Revenue Market Share by Player in 2024
 Figure 18. Tofranil Revenue Market Share by Player in 2024
 Figure 19. Others Revenue Market Share by Player in 2024
 Figure 20. Global Enuresis Treatment Drugs Revenue Market Share by Type (2020-2031)
 Figure 21. Global Enuresis Treatment Drugs Revenue Market Share by Application (2020-2031)
 Figure 22. North America Enuresis Treatment Drugs Revenue YoY (2020-2031) & (US$ Million)
 Figure 23. North America Top 5 Players Enuresis Treatment Drugs Revenue (US$ Million) in 2024
 Figure 24. North America Enuresis Treatment Drugs Revenue (US$ Million) by Type (2020 - 2031)
 Figure 25. North America Enuresis Treatment Drugs Revenue (US$ Million) by Application (2020-2031)
 Figure 26. US Enuresis Treatment Drugs Revenue (2020-2031) & (US$ Million)
 Figure 27. Canada Enuresis Treatment Drugs Revenue (2020-2031) & (US$ Million)
 Figure 28. Mexico Enuresis Treatment Drugs Revenue (2020-2031) & (US$ Million)
 Figure 29. Europe Enuresis Treatment Drugs Revenue YoY (2020-2031) & (US$ Million)
 Figure 30. Europe Top 5 Players Enuresis Treatment Drugs Revenue (US$ Million) in 2024
 Figure 31. Europe Enuresis Treatment Drugs Revenue (US$ Million) by Type (2020-2031)
 Figure 32. Europe Enuresis Treatment Drugs Revenue (US$ Million) by Application (2020-2031)
 Figure 33. Germany Enuresis Treatment Drugs Revenue (2020-2031) & (US$ Million)
 Figure 34. France Enuresis Treatment Drugs Revenue (2020-2031) & (US$ Million)
 Figure 35. U.K. Enuresis Treatment Drugs Revenue (2020-2031) & (US$ Million)
 Figure 36. Italy Enuresis Treatment Drugs Revenue (2020-2031) & (US$ Million)
 Figure 37. Russia Enuresis Treatment Drugs Revenue (2020-2031) & (US$ Million)
 Figure 38. Asia-Pacific Enuresis Treatment Drugs Revenue YoY (2020-2031) & (US$ Million)
 Figure 39. Asia-Pacific Top 8 Players Enuresis Treatment Drugs Revenue (US$ Million) in 2024
 Figure 40. Asia-Pacific Enuresis Treatment Drugs Revenue (US$ Million) by Type (2020-2031)
 Figure 41. Asia-Pacific Enuresis Treatment Drugs Revenue (US$ Million) by Application (2020-2031)
 Figure 42. Indonesia Enuresis Treatment Drugs Revenue (2020-2031) & (US$ Million)
 Figure 43. Japan Enuresis Treatment Drugs Revenue (2020-2031) & (US$ Million)
 Figure 44. South Korea Enuresis Treatment Drugs Revenue (2020-2031) & (US$ Million)
 Figure 45. Australia Enuresis Treatment Drugs Revenue (2020-2031) & (US$ Million)
 Figure 46. India Enuresis Treatment Drugs Revenue (2020-2031) & (US$ Million)
 Figure 47. Indonesia Enuresis Treatment Drugs Revenue (2020-2031) & (US$ Million)
 Figure 48. Vietnam Enuresis Treatment Drugs Revenue (2020-2031) & (US$ Million)
 Figure 49. Malaysia Enuresis Treatment Drugs Revenue (2020-2031) & (US$ Million)
 Figure 50. Philippines Enuresis Treatment Drugs Revenue (2020-2031) & (US$ Million)
 Figure 51. Singapore Enuresis Treatment Drugs Revenue (2020-2031) & (US$ Million)
 Figure 52. Central and South America Enuresis Treatment Drugs Revenue YoY (2020-2031) & (US$ Million)
 Figure 53. Central and South America Top 5 Players Enuresis Treatment Drugs Revenue (US$ Million) in 2024
 Figure 54. Central and South America Enuresis Treatment Drugs Revenue (US$ Million) by Type (2020-2031)
 Figure 55. Central and South America Enuresis Treatment Drugs Revenue (US$ Million) by Application (2020-2031)
 Figure 56. Brazil Enuresis Treatment Drugs Revenue (2020-2025) & (US$ Million)
 Figure 57. Argentina Enuresis Treatment Drugs Revenue (2020-2025) & (US$ Million)
 Figure 58. Middle East and Africa Enuresis Treatment Drugs Revenue YoY (2020-2031) & (US$ Million)
 Figure 59. Middle East and Africa Top 5 Players Enuresis Treatment Drugs Revenue (US$ Million) in 2024
 Figure 60. South America Enuresis Treatment Drugs Revenue (US$ Million) by Type (2020-2031)
 Figure 61. Middle East and Africa Enuresis Treatment Drugs Revenue (US$ Million) by Application (2020-2031)
 Figure 62. GCC Countries Enuresis Treatment Drugs Revenue (2020-2025) & (US$ Million)
 Figure 63. Israel Enuresis Treatment Drugs Revenue (2020-2025) & (US$ Million)
 Figure 64. Egypt Enuresis Treatment Drugs Revenue (2020-2025) & (US$ Million)
 Figure 65. South Africa Enuresis Treatment Drugs Revenue (2020-2025) & (US$ Million)
 Figure 66. Enuresis Treatment Drugs Industry Chain Mapping
 Figure 67. Channels of Distribution (Direct Vs Distribution)
 Figure 68. Bottom-up and Top-down Approaches for This Report
 Figure 69. Data Triangulation
 Figure 70. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$4900

This license allows only one user to access the PDF.
Electronic (PDF)

$7350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$9800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Novocure

SIMILAR REPORTS

Global Drugs for Enuresis Market Research Report 2025
Global Constipation Treatment Drug Market Research Report 2025
Global Chronic Constipation Treatment Drugs Market Research Report 2024
Urinary Incontinence Treatment Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Urinary Incontinence Drug Market Research Report 2025
Global Urinary Incontinence Care Product Market Research Report 2024
Bladder Control Products for Urinary Incontinence Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Female Urinary Incontinence Treatment Market Research Report 2024
Global Drugs for Sexual Dysfunction Market Research Report 2024
Global Urinary Products Market Research Report 2025
Global Incontinence Protection Market Research Report 2025
Global Severe Incontinence Products Market Research Report 2024
Incontinence Treatment System Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Antidiuretic Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Female Urinary Incontinence Products Market Research Report 2024
Global Urinary Control System Market Research Report 2024
Global Digital Therapy for Urinary Incontinence Market Research Report 2024
Global Hydration Bladder Market Research Report 2024
Male Incontinence Treatment Device Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Reusable Incontinence Products Market Research Report 2024
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions